Product Information

ARIPIPRAZOLE 30 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1843 per EA under NDC 27241005608. Its NADAC has been published 458 times since Feb 14, 2018.

FDA first approved this application on Sep 12, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ARIPIPRAZOLE 30 MG TABLET

Aripiprazole
$0.1843per EA

Strength

30 mg/1

NDC

27241005608

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ARIPIPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA206174

FDA Approved

9/12/2016

TE Code

AB

On Market Since

5/30/2017

Pharmacological Classes

Price Statistics

The NADAC for ARIPIPRAZOLE 30 MG TABLET has been published 458 times since Feb 14, 2018, and over the history we have for it it has declined 79.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1843 per EA
All-time high$0.8982 (Feb 14, 2018)
All-time low$0.1365 (Nov 20, 2024)
52-week high$0.1843
52-week low$0.1567
Median price$0.2757
Average price$0.3099
Largest weekly change+41.4% (Aug 21, 2024)
Weeks tracked458
Tracking sinceFeb 14, 2018

Price History

1W

+0.8%

1M

+6.2%

3M

+12.0%

6M

+5.6%

1Y

+6.4%

3Y

-15.3%

5Y

-33.9%

All

-79.5%

Generic Alternatives

The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ARIPIPRAZOLE 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 30 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.1843 per EA (NDC 27241005608), effective Nov 18, 2026.

How has the price of ARIPIPRAZOLE 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for ARIPIPRAZOLE 30 MG TABLET has declined 79.5%. It has been tracked across 458 weekly CMS publications since Feb 14, 2018.

What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 30 MG TABLET?

Since Feb 14, 2018, the NADAC for ARIPIPRAZOLE 30 MG TABLET has ranged from a low of $0.1365 (Nov 20, 2024) to a high of $0.8982 (Feb 14, 2018), with a median of $0.2757 per EA.

Are there cheaper alternatives to ARIPIPRAZOLE 30 MG TABLET?

Yes. 14 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ARIPIPRAZOLE 30 MG TABLET, is $0.1834 per EA — about 0% below ARIPIPRAZOLE 30 MG TABLET.

Who manufactures ARIPIPRAZOLE 30 MG TABLET?

ARIPIPRAZOLE 30 MG TABLET (NDC 27241005608) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.